NCI-COG Pediatric MATCH
NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice) Screening Protocol
More Information
- Trial Status
- Accepting patients
- Trial Phase
- Phase 2
- Enrollment
- 2,316 patients (estimated)
- Sponsors
- National Cancer Institute (NCI)
- Tags
- ALK Inhibitor, EphA2 Inhibitor
- Trial Type
- Treatment
- Last Update
- 2 months ago
- SparkCures ID
- 1712
- NCT Identifier
- NCT03155620
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print this trial to share with your doctor.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.